Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Adyen
|
| gptkbp:administered_by |
antigens
|
| gptkbp:approves |
human use
|
| gptkbp:associated_with |
safety profile
|
| gptkbp:contains |
alum
monophosphoryl lipid A |
| gptkbp:developed_by |
gptkb:Glaxo_Smith_Kline
preventing infections adjuvanted vaccines |
| gptkbp:enhances |
immune response
antigen presentation long-term immunity immune tolerance cell-mediated immunity T-cell response vaccine stability memory response vaccine response in adolescents |
| gptkbp:first_introduced |
gptkb:Hepatitis_B_vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
AS04 adjuvant system
|
| gptkbp:improves |
vaccine efficacy
immune response in children seroconversion rates vaccine response in adults vaccine response in elderly vaccine response in high-risk populations vaccine response in immunocompromised individuals |
| gptkbp:increased |
vaccine safety
vaccine uptake antibody production vaccine coverage rates vaccine effectiveness vaccine compliance vaccine response in infants vaccine response in pregnant women vaccine response in the elderly CD4+ T-cell activation |
| gptkbp:influences |
immune memory
Th1/ Th2 balance |
| gptkbp:ingredients |
lipid A
|
| gptkbp:is_utilized_in |
clinical trials
|
| gptkbp:promotes |
immune system activation
Th2 response B-cell activation Th1 response |
| gptkbp:supports |
public health initiatives
vaccine development vaccine formulation vaccine research. |
| gptkbp:used_in |
gptkb:HPV_vaccine
gptkb:rabies_vaccine gptkb:varicella_vaccine vaccines COVID-19 vaccine trials pneumococcal vaccine influenza vaccine diphtheria vaccine tetanus vaccine hepatitis A vaccine meningococcal vaccine |
| gptkbp:bfsParent |
gptkb:Cervarix
|
| gptkbp:bfsLayer |
5
|